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Abstract. Genetic predispositions associated with metabolism of the amyloid- protein precursor underlie familial
Alzheimer’s disease; a form of dementia characterized by early disease onset and elevated levels of cortical amyloid-.
Human exposure to aluminum is linked to the etiology of Alzheimer’s disease and recent research measured a high content
of aluminum in brain tissue in familial Alzheimer’s disease. To elaborate upon this finding, we have obtained brain tissues
from a Colombian cohort of donors with familial Alzheimer’s disease. We have used established methods to measure the
aluminum content of these tissues and we have compared the data with a recently measured dataset for control brain tissues.
We report significantly higher levels of aluminum in brain tissues in donors with familial Alzheimer’s disease than in control
tissues from donors without neurological impairment or neurodegeneration. We have used aluminum-specific fluorescence
microscopy along with complementary imaging for amyloid- to demonstrate a very high degree of co-localization of these
two risk factors in brain tissue in familial Alzheimer’s disease. Aluminum and amyloid-were co-located in senile plaques as
well as vasculature, the latter resembling cerebral amyloid angiopathy. Aluminum was also found separately from amyloid-
in intracellular compartments including glia and neuronal axons. The research has identified an arguably unique association
between high brain aluminum content and amyloid- and allows postulation that genetic predispositions defining familial
Alzheimer’s disease underlie this relationship.
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INTRODUCTION23
An association between aluminum and amyloid-24
in Alzheimer’s disease has been postulated for25
40 years [1]. It has not been without controversy26
[2] though a consensus does now support the co-27
localization if not co-deposition of these two major28
risk factors in Alzheimer’s disease [3]. Familial29
Alzheimer’s disease, fAD, is characterized by genetic30
mutations affecting the expression and metabolism31
of the amyloid- protein precursor (APP), leading32
to early onset of disease [4, 5]. One fAD mutation33
∗Correspondence to: Professor Christopher Exley, The Birchall
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shire, ST5 5BG, United Kingdom. E-mail: c.exley@keele.ac.uk.
is PS1-E280A (Glu280Ala), a mutation that occurs 34
in a significant cohort of individuals in Colombia. 35
The mutation results in elevated cortical levels of 36
amyloid-, early disease onset (<50 years of age) and 37
an aggressive disease etiology [6]. 38
Previous research on brain tissue from 12 donors 39
diagnosed as fAD [7] demonstrated significant accu- 40
mulations of aluminum with 11 of the 12 brains 41
having at least one tissue sample where the concen- 42
tration of aluminum was defined as pathologically 43
concerning (≥3.00g/g dry wt.). Aluminum-specific 44
fluorescence microscopy [8] confirmed the pres- 45
ence of aluminum in these tissues and suggested 46
that the majority of deposits of aluminum were 47
extracellular associated with neuronal and cellular 48
debris. A tentative suggestion was made that alu- 49
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minum and amyloid- were co-located in a senile50
plaque-like structure. Herein we have measured alu-51
minum in brain tissue in Colombian donors carrying52
the fAD mutation PS1-E280A and compared the53
data with data for control brains. We have also54
used aluminum-specific fluorescence microscopy to55
investigate interrelationships between aluminum and56
amyloid- in fAD.57
MATERIALS AND METHODS58
Human brain tissues59
Brain tissues, frozen and fixed, from donors who60
carried the PS1-E280A mutation were obtained from61
the brain bank of the Universidad de Antioquia,62
Medellin, Colombia and research was carried our fol-63
lowing ethical approval by Keele University (ERP64
2391). The consultant neuropathologist at the Lon-65
don Neurodegenerative Diseases Brain Bank chose66
the control brain tissues for us and their detailed67
data are presented elsewhere (Exley and Clarkson,68
unpublished).69
Measurement of aluminum in fAD brain tissues70
The aluminum content of tissues was measured by71
an established and fully validated method [9] that72
herein is described only briefly. Samples of cortex,73
between 0.6 and 2.0 g in weight, were thawed at74
room temperature and cut using a stainless-steel blade75
into sections approximately 0.3–0.5 g in weight. Tis-76
sues were dried for 48 h, to a constant weight, in an77
incubator at 37◦C. Dry and thereafter weighed tis-78
sues were digested in a microwave (MARS Xpress79
CEM Microwave Technology Ltd.) in a mixture of80
1 mL 15.8M HNO3 (Fisher Analytical Grade) and81
1 mL 30% w/v H2O2 (BDH Aristar). The result-82
ing digests were clear with no fatty residues and,83
upon cooling, were made up to 5 mL volume using84
ultrapure water (cond. <0.067S/cm). Total alu-85
minum was measured in each sample by transversely86
heated graphite furnace atomic absorption spectrom-87
etry (TH GFAAS) using matrix-matched standards88
and an established analytical program alongside pre-89
viously validated quality assurance data [9]. The90
latter included method blanks, detailed descriptions91
of which have been published recently [10].92
Microtomy93
All chemicals were from Sigma Aldrich, UK94
unless otherwise stated. Paraffin-embedded brain tis-95
Table 1
Aluminum content (g/g dry wt.) of brain tissues from Colombian
donors with a diagnosis of familial Alzheimer’s disease
Case ID Gender Age Brain Region – Lobe
Occipital Temporal Frontal Parietal
225 Male 48 2.21 3.07 1.20 1.02
1.20 0.81 11.81
4.78
213 Male 55 8.54 1.40 1.05 1.82
2.71 2.19 1.22 2.67
1.05 2.31
244 Male 55 1.60 5.35 2.33 6.48
193 Male 48 0.41 1.03 1.10 0.64
0.54 1.47 0.27 0.53
0.83 1.02
189 Female 52 1.10 5.83 0.70 4.90
3.22
163 Female 68 5.06 2.36 1.89 4.62
3.90 3.34
2.19
178 Male 59 0.30 1.49 0.88 0.44
1.54 0.49
0.86
023 Male 61 2.04 1.29
088 Female 50 3.57 7.42 3.49
0.62
237 Male 53 1.07 1.92 4.12 1.72
1.35 8.01 10.27 1.88
1.63
77 Female 54 6.27 5.68 4.68 9.73
9.38 42.50 6.95
22.17
31.30
204 Male 52 31.16 4.92 16.44 2.05
33.48 6.88 9.83
5.47
Data are for all tissue samples measured with 1–4 replicates per
lobe.
sue blocks mounted on Tissue Tek® Uni-cassettes® 96
(Sakura Finetek Europe B.V., Netherlands), were 97
cooled on wet ice for 10 min and sectioned at 5m via 98
the use of a rotary RM2025 microtome using Surgi- 99
path DB80 LX low-profile stainless-steel microtome 100
blades (both from Leica Microsystems, UK). Adja- 101
cent and numbered serial sections were floated out 102
on ultrapure water (cond. <0.067S/cm) at 45◦C 103
and lifted onto SuperFrost® Plus slides (Thermo Sci- 104
entific, UK). Sections were subsequently dried at 105
ambient temperature overnight. Dried sections were 106
heated at 62◦C for 20 min and allowed to cool to 107
ambient temperature, immediately prior to use. 108
Deparaffinization and rehydration of 109
paraffin-embedded tissue sections 110
Tissue sections were deparaffinized and rehydrated 111
through 250 mL of the following reagents: Histo- 112
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Fig. 1. Aluminum and amyloid- deposition in a senile plaque in the occipital cortex of a donor with familial Alzheimer’s disease (fAD).
A) Aluminum is identified using lumogallion as an orange fluorescence emission. B) Thioflavin S (ThS) staining of an adjacent serial
section revealed a green fluorescence emission characteristic of amyloid-. C) Merging of fluorescence channels reveals co-localization
of aluminum and amyloid-. D) Congo red staining confirmed the presence of amyloid- in the same plaque, producing a red hue under
bright-field illumination and apple-green birefringence (magnified insert denoted by an asterisk) under polarized light. Magnification: X
400, scale bars = 50m.
Clear (National Diagnostics, US) for 3 min, fresh113
Histo-Clear for 1 min, 100% v/v ethanol (HPLC grade114
used throughout) for 2 min and 95, 70, 50, and 30%115
v/v ethanol for 1 min. Slides were finally rehydrated116
via immersion into ultrapure water for 35 s. Sections117
were agitated throughout processing. For fluores-118
cence microscopy, rehydrated tissue sections were119
subsequently outlined with a hydrophobic PAP pen120
allowing for staining in moisture chambers.121
Lumogallion staining122
Lumogallion (4-chloro-3-(2,4-dihydroxyphenyla123
zo)-2-hydroxybenzene-1-sulphonic acid, TCI124
Europe N.V., Belgium) staining was performed as125
described elsewhere [11]. Briefly, lumogallion pre-126
pared at 1 mM in 50 mM PIPES, pH 7.4 was added127
to PAP-outlined sections in moisture chambers for128
45 min. Autofluorescence of the non-stained sections 129
made use of the PIPES buffer only. Following 130
staining, sections were rinsed in the same PIPES 131
buffer and washed for 30 s in ultrapure water, prior 132
to mounting with Fluoromount™. 133
Amyloid-β staining 134
Congo red and thioflavin S (ThS) staining was per- 135
formed as previously described [12]. Briefly, Congo 136
red staining was performed via immersion of rehy- 137
drated tissue sections into 0.5% w/v Congo red in 50% 138
v/v ethanol for 5 min, rinsing in 0.2% w/v potassium 139
hydroxide in 80% v/v ethanol for 3 s and washing in 140
ultrapure water for 30 s. Sections were mounted with 141
Faramount (Agilent Dako, UK). For ThS staining, 142
rehydrated sections were stained in moisture cham- 143
bers with ca 0.075% w/v ThS in 50% v/v ethanol 144
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Fig. 2. Aluminum and amyloid- co-located in a senile plaque in the grey-white matter interface of the parietal lobe of a donor with fAD. A)
Aluminum was detected via an orange fluorescence emission upon lumogallion staining. B) ThS-reactive fluorescence (green) indicative of
amyloid- in the identical senile plaque. C) Merging of fluorescence channels reveals co-localization of aluminum and amyloid-. D) Congo
red staining of the same tissue region revealed apple-green birefringence in the form of a Maltese-Cross diffraction pattern or spherulite
(magnified insert), under polarized light. Magnification: X 400, scale bars = 50m.
for 8 min, twice rinsed for 10 s in 80% v/v ethanol145
and washed in ultrapure water for 30 s. Sections were146
mounted with Fluoromount™.147
Fluorescence microscopy148
Fluorescence, brightfield, and polarized light149
microscopy were performed via use of an Olympus150
BX50 fluorescence microscope (mercury source),151
equipped with a BX-FLA reflected light attachment.152
Lumogallion fluorescence was collected through an153
Olympus U-MNIB3 fluorescence filter cube (excita-154
tion filter: 470–495 nm, dichromatic mirror: 505 nm,155
longpass emission filter: 510 nm) and ThS fluores-156
cence collected by use of an Olympus U-MWBV2157
cube (excitation filter: 400–440 nm, dichromatic158
mirror: 455 nm, longpass emission filter: 475 nm).159
Polarized light illumination was achieved by use of160
a U-POT drop-in polarizer and a U-ANT transmit- 161
ted light analyzer (both from Olympus, UK). Images 162
were acquired by use of a ColorView III charged cou- 163
pled device (CCD) camera and the CellD software 164
suite (Olympus, SiS Imaging Solutions, GmbH). Flu- 165
orescence channels were merged using Photoshop 166
(Adobe Systems Inc., USA). 167
Statistical analyses 168
Data for aluminum content of tissues were skewed 169
and were not normally distributed. For descriptive 170
summary statistics, the median and interquartile- 171
range were calculated for each donor, each lobe, 172
sex and group. For all test statistics and mod- 173
els, aluminum content data were log transformed. 174
Due to unbalanced groups (fAD donors = 12, con- 175
trol donors = 20) and unbalanced numbers of samples 176
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Fig. 3. Aluminum deposition in a senile plaque in the temporal cortex of a donor with fAD. A) Autofluorescence of the non-stained
section revealed a weak green fluorescence emission of a plaque-like structure. B) Aluminum identified as orange fluorescence upon
lumogallion staining. C) ThS staining showed the presence of a senile plaque via an intense green fluorescence emission. D) Merging of
the lumogallion and ThS fluorescence channels identified aluminum at the core of the senile plaque with ThS reactive threads of amyloid-
identified at its periphery (white arrows). Magnified inserts are denoted by asterisks in the respective fluorescence micrographs. Magnification:
X 400, scale bars = 50m.
per donor and lobe, mixed effect models including177
random effects for donors and lobe were used [13].178
First, a model was calculated for the fAD group to179
analyze differences between the factors lobes, gen-180
der, and associations with the covariate age. The181
model contains all these factors as main terms without182
interactions. Additional random effects were nested183
and included the factors number of samples, nested184
within lobe and donor.185
A second model included the factor group, to ana-186
lyze differences between the fAD and the control187
groups. We considered a p-value smaller than 0.05188
to be statistically significant. To obtain pairwise dif-189
ferences between lobes post hoc tests with Tukey190
correction were performed with the function glht191
from the R package multcomp. For all analysis RStu-192
dio Version 1.1.463 © 2009–2018 were used.193
RESULTS 194
Aluminum content of fAD brain tissues 195
The aluminum content of brain tissue across 196
all donors and all brain regions ranged from 0.30 197
to 33.48g/g dry wt. (Table 1). The majority of 198
tissues (45 out of 83) had an aluminum content 199
above 1.99g/g dry wt. with 14, 24, 10, and 200
35 tissues having contents in the range <1.00, 201
1.00–1.99, 2.00–2.99, and≥3.00g/g dry wt. respec- 202
tively. The median (IQR) aluminum content for 203
each lobe was 2.04 (1.09–5.67), 2.19 (1.44–5.14), 204
2.11 (1.04–4.88), and 2.31 (1.02–6.48) for occipi- 205
tal, temporal, frontal, and parietal, respectively. There 206
were no significant differences in aluminum content 207
between lobes. There was no significant relation- 208
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Fig. 4. Cerebral amyloid angiopathy (CAA) in a blood vessel in the frontal cortex of a donor with fAD. A) Autofluorescence revealed a
weak green fluorescence emission of the vessel wall. B) Lumogallion revealed the presence of aluminum (orange fluorescence) in the same
vessel. C) Positive ThS-staining identifies amyloid- in the vessel wall. D) Apple-green birefringence when stained with Congo red under
polarized light is indicative of amyloid- in a  sheet conformation. White arrows highlight mineralized deposits appearing as spherulites,
producing a Maltese-Cross diffraction pattern. Magnification: X 400, scale bars = 50m.
ship between age of donor and aluminum content.209
There was a significant difference in aluminum210
content (median and IQR) between genders (Sup-211
plementary Figure 1) with females (4.68; 3.22–6.95)212
having a higher content than males (1.62; 1.04–3.86)213
(p = 0.01951).214
Comparison with control brain tissues215
The aluminum content (median and IQR) of216
fAD brain tissues (2.19; 1.10–5.41) was signifi-217
cantly higher (p < 0.001) than control tissues (0.60;218
0.35–0.98; Supplementary Figure 2).219
Imaging of aluminum and amyloid-β in fAD220
Aluminum-specific fluorescence microscopy con-221
firmed the presence of significant numbers of deposits222
of aluminum in brain tissue from all donors across 223
all four lobes and in grey and white matter. Approx- 224
imately two thirds of aluminum deposits were 225
identified in grey matter. The majority of all deposits 226
of tissue aluminum were shown to be extracellu- 227
lar and in most cases (71 out of 89), as confirmed 228
using both ThS and Congo red, were co-located 229
with amyloid-. Tissue aluminum emitted charac- 230
teristic orange fluorescence and was often senile 231
plaque-like in size and appearance (Figs. 1A, 2A). 232
Complementary staining of both same and serial sec- 233
tions using ThS and/or Congo red identified these 234
aluminum-rich deposits as being additionally com- 235
posed of amyloid- (Figs. 1B, 2B) with merged 236
images demonstrating intimate associations between 237
amyloid and the metal (Figs. 1C, 2C). Congo red 238
in combination with polarized light confirmed the 239
presence of -sheet amyloid- in these plaque-like 240
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Fig. 5. Intracellular aluminum in glial cells in the occipital cortex (A) and in neuronal axons in white matter of the parietal lobe (B) of
donors with fAD. C, D) Autofluorescence of unstained serial sections confirming the presence of aluminum. Magnified inserts are denoted
by asterisks in the respective fluorescence micrographs. Magnification: X 400, scale bars = 50m.
structures (Figs. 1D, 2D). In some structures, alu-241
minum appeared to be associated with a core of242
amyloid- (Fig. 3A–C) surrounded by a ‘nest’ of243
ThS-positive amyloid threads (Fig. 3C, D). There was244
also evidence of classical cerebral amyloid angiopa-245
thy where blood vessel walls stained positively for246
both aluminum and amyloid- with the latter show-247
ing characteristic apple-green birefringence under248
polarized light (Fig. 4A–D). Occasional ThS-positive249
deposits were identified as spherulites by their clas-250
sical Maltese cross signature under polarized light251
(Fig. 4C, D). Occasionally aluminum was identi-252
fied in intracellular locations in tissues including253
in glia-like cells (Fig. 5A) and in neuronal axons254
(Fig. 5B).255
DISCUSSION256
The aluminum content of brain tissue from donors257
with the PS1-E280A fAD mutation was universally258
high with 42% of tissues having a concentration of259
aluminum above 3.00g/g dry wt., a content con-260
sidered as pathologically significant [10]. Aluminum 261
content in brain tissue in fAD was significantly higher 262
than brain tissues from donors with neither clinical 263
nor neuropathological diagnosis of neurodegener- 264
ative disease (Exley and Clarkson, unpublished). 265
The new data confirm unequivocally the previous 266
observation of very high brain aluminum con- 267
tent in fAD [7]. Aluminum-specific fluorescence 268
microscopy identified aluminum in all brain tissues 269
investigated (Figs. 1–5). The majority of all deposits 270
of aluminum were extracellular and predominantly 271
co-located with amyloid- in primarily senile plaques 272
and occasionally the vasculature. While the pre- 273
dominance of aluminum-amyloid deposits and the 274
frequency with which aluminum and amyloid-were 275
observed together suggested their co-deposition, 276
detailed scrutiny of the images favored their co- 277
localization. For example, with either aluminum or 278
amyloid- acting as a nidus for the precipitation of the 279
other. Deposits of both aluminum and amyloid were 280
identified in the absence of each other. The former 281
were found in a number of intracellular environ- 282
ments including in microglia-like cells and associated 283
Un
co
rre
cte
d A
uth
or
 P
ro
of
8 M. Mold et al. / Aluminum and Amyloid- in Familial AD
with neuronal axons. The presence of aluminum in284
axons in fAD brain tissues might imply an associ-285
ation with tau protein [14] though such remains to286
be confirmed.287
This is the second study confirming significantly288
high brain aluminum content in fAD but it is the first289
to demonstrate an unequivocal association between290
the location of aluminum and amyloid- in fAD.291
It shows that two prominent risk factors in the eti-292
ology of AD [15, 16] are intimately interwoven in293
the neuropathology of fAD. While there is a long294
history suggesting a role for aluminum in the prove-295
nance of senile plaques [17], the observation herein296
of the co-localization of aluminum and amyloid-297
in vasculature has not previously been seen in either298
cerebral amyloid angiopathy [18] or autism spectrum299
disorder (Mold and Exley, unpublished). The asso-300
ciation of aluminum and amyloid- in brain tissue301
in neurodegenerative disease is not inevitable and so302
raises the question, what is different about fAD? The303
two distinct populations of fAD studied, previously304
[7] and herein, share a single characteristic in being305
prone to elevated levels of cortical amyloid- early306
in life. This is attributed to genetic mutations associ-307
ated with the metabolic machinery processing APP308
[1, 4, 5]. However, are the elevated levels of corti-309
cal amyloid-, as opposed to cerebral spinal fluid310
amyloid- [19], the direct consequence of enzymatic311
processing of APP or, perhaps, the indirect effect312
of elevated levels of brain aluminum? Might genetic313
predispositions underlying fAD be responsible for314
increased uptake and retention of aluminum in brain315
tissue with elevated amyloid- being an indirect or316
even direct consequence of such. One could envis-317
age increased amyloid- in brain tissue as either an318
ameliorative response to high brain aluminum con-319
tent or simply adventitious, aluminum acting as a320
nidus for the precipitation of amyloid-. Either way it321
does seem indisputable that aluminum and amyloid-322
 are inextricably linked in the neuropathology323
of fAD.324
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